The use of genotyping in antimalarial clinical trials: a systematic review of published studies from 1995–2005

[1]  C. Karema,et al.  Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[2]  H. Mshinda,et al.  Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub‐Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness , 2006, Tropical medicine & international health : TM & IH.

[3]  P. Newton,et al.  An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos) , 2006, Tropical medicine & international health : TM & IH.

[4]  K. Stepniewska,et al.  Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison , 2006, The Lancet.

[5]  F. Nosten,et al.  A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  P. Rosenthal,et al.  Distinguishing recrudescences from new infections in antimalarial clinical trials: major impact of interpretation of genotyping results on estimates of drug efficacy. , 2005, The American journal of tropical medicine and hygiene.

[7]  U. d’Alessandro,et al.  Plasmodium falciparum genotyping by microsatellites as a method to distinguish between recrudescent and new infections. , 2005, The American journal of tropical medicine and hygiene.

[8]  C. Karema,et al.  Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria , 2004, Tropical medicine & international health : TM & IH.

[9]  A. Hubbard,et al.  Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. , 2003, The American journal of tropical medicine and hygiene.

[10]  J. M. Rubio,et al.  Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[11]  G. Snounou,et al.  The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment. , 1998, Parasitology today.

[12]  O. Doumbo,et al.  Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. , 1995, The American journal of tropical medicine and hygiene.

[13]  Weltgesundheitsorganisation.  World malaria report , 2005 .

[14]  F. Nosten,et al.  Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. , 1999, The American journal of tropical medicine and hygiene.